Alzheimer disease: Plasma clusterin predicts degree of pathogenesis in AD

Abstract

Plasma levels of clusterin, a chaperone protein that regulates amyloid formation and clearance, indicate that blood-based biomarkers could identify individuals at risk of developing alzheimer disease (aD), according to a study published in Archives of General Psychiatry. “the results of this study demonstrate that this protein, which has an established role… (More)
DOI: 10.1038/nrneurol.2010.122

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics